Article Information
History
- September 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Francesca Castroa,*,
- Richa Parikhb,*,
- Jelyn C. Eustaquioc,
- Andriy Derkachd,
- Janine M. Josephe,
- Alexander M. Lesokhina,f,
- Saad Z. Usmania,f and
- Urvi A. Shaha,f,†
- aMyeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
- bDepartment of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI
- cJacobs School of Medicine and Biomedical Science, University at Buffalo
- dDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center
- eDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center
- fDepartment of Medicine, Weill Cornell Medical College
- ↵†Corresponding Author: Urvi A. Shah, MD, 530 E 74th St, New York, NY 10021., Phone: 646-608-3713, Email address: shahu{at}mskcc.org
↵* These authors contributed equally to this work